The fully linked HTML version of this article has now been published.
JCS ePress
online publication date 2 Mar 2004
doi: 10.1242/jcs.01037
Research Article
Membrane-associated HB-EGF modulates HGF-induced cellular responses in MDCK cells
Amar B. Singh,
Toshiaki Tsukada,
Roy Zent,
and
Raymond C. Harris*
* Author for correspondence (e-mail: ray.harris{at}vanderbilt.edu)
In MDCK cells, hepatocyte growth factor/scatter factor (HGF/SF) induces epithelial cell dissociation, scattering, migration, growth and formation of branched tubular structures. By contrast, these cells neither scatter nor form tubular structures in response to the epidermal growth factor (EGF) family of growth factors. Heparin-binding EGF-like growth factor (HB-EGF) is a member of the EGF family of growth factors and is synthesized as a membrane-associated precursor molecule (proHB-EGF). ProHB-EGF is proteolytically cleaved to release a soluble ligand (sHB-EGF) that activates the EGF receptor. Although recent studies suggest possible physiological functions, the role of proHB-EGF remains largely undefined. Using MDCK cells stably expressing proHB-EGF, a noncleavable deletion mutant of proHB-EGF or soluble HB-EGF, we show that epithelial cell functions differ depending on the form of HB-EGF being expressed. Expression of noncleavable membrane-anchored HB-EGF promoted cell-matrix and cell-cell interactions and decreased cell migration, HGF/SF-induced cell scattering and formation of tubular structures. By contrast, expression of soluble HB-EGF induced increased cell migration, decreased cell-matrix and cell-cell interactions and promoted the development of long unbranched tubular structures in response to HGF/SF. These findings suggest that HB-EGF can not only modulate HGF/SF-induced cellular responses in MDCK cells but also that membrane-bound HB-EGF and soluble HB-EGF give rise to distinctly different effects on cell-cell and cell-extracellular matrix interactions.
This article has been cited by other articles:
|
|
|
|
 
S. Buvinic, M. Bravo-Zehnder, J. L. Boyer, J. P. Huidobro-Toro, and A. Gonzalez
Nucleotide P2Y1 receptor regulates EGF receptor mitogenic signaling and expression in epithelial cells
J. Cell Sci.,
December 15, 2007;
120(24):
4289 - 4301.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. B. Singh, K. Sugimoto, and R. C. Harris
Juxtacrine Activation of Epidermal Growth Factor (EGF) Receptor by Membrane-anchored Heparin-binding EGF-like Growth Factor Protects Epithelial Cells from Anoikis While Maintaining an Epithelial Phenotype
J. Biol. Chem.,
November 9, 2007;
282(45):
32890 - 32901.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. B. Singh, K. Sugimoto, P. Dhawan, and R. C. Harris
Juxtacrine activation of EGFR regulates claudin expression and increases transepithelial resistance
Am J Physiol Cell Physiol,
November 1, 2007;
293(5):
C1660 - C1668.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Llamazares, A. J. Obaya, A. Moncada-Pazos, R. Heljasvaara, J. Espada, C. Lopez-Otin, and S. Cal
The ADAMTS12 metalloproteinase exhibits anti-tumorigenic properties through modulation of the Ras-dependent ERK signalling pathway
J. Cell Sci.,
October 15, 2007;
120(20):
3544 - 3552.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Wang, C. Sloss, X. Zhang, S. W. Lee, and J. C. Cusack
Membrane-Bound Heparin-Binding Epidermal Growth Factor Like Growth Factor Regulates E-Cadherin Expression in Pancreatic Carcinoma Cells
Cancer Res.,
September 15, 2007;
67(18):
8486 - 8493.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. B. Forsyth, A. Banan, A. Farhadi, J. Z. Fields, Y. Tang, M. Shaikh, L. J. Zhang, P. A. Engen, and A. Keshavarzian
Regulation of Oxidant-Induced Intestinal Permeability by Metalloprotease-Dependent Epidermal Growth Factor Receptor Signaling
J. Pharmacol. Exp. Ther.,
April 1, 2007;
321(1):
84 - 97.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. C. Montero, R. Rodriguez-Barrueco, L. Yuste, P. P. Juanes, J. Borges, A. Esparis-Ogando, and A. Pandiella
The Extracellular Linker of pro-Neuregulin-{alpha}2c Is Required for Efficient Sorting and Juxtacrine Function
Mol. Biol. Cell,
February 1, 2007;
18(2):
380 - 393.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Kim, R. M. Adam, and M. R. Freeman
Trafficking of Nuclear Heparin-Binding Epidermal Growth Factor-like Growth Factor into an Epidermal Growth Factor Receptor-Dependent Autocrine Loop in Response to Oxidative Stress
Cancer Res.,
September 15, 2005;
65(18):
8242 - 8249.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Dong, L. K. Opresko, W. Chrisler, G. Orr, R. D. Quesenberry, D. A. Lauffenburger, and H. S. Wiley
The Membrane-anchoring Domain of Epidermal Growth Factor Receptor Ligands Dictates Their Ability to Operate in Juxtacrine Mode
Mol. Biol. Cell,
June 1, 2005;
16(6):
2984 - 2998.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Tomar, Y. Wang, N. Kumar, S. George, B. Ceacareanu, A. Hassid, K. E. Chapman, A. M. Aryal, C. M. Waters, and S. Khurana
Regulation of Cell Motility by Tyrosine Phosphorylated Villin
Mol. Biol. Cell,
November 1, 2004;
15(11):
4807 - 4817.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. L. Hinkle, S. W. Sunnarborg, D. Loiselle, C. E. Parker, M. Stevenson, W. E. Russell, and D. C. Lee
Selective Roles for Tumor Necrosis Factor {alpha}-converting Enzyme/ADAM17 in the Shedding of the Epidermal Growth Factor Receptor Ligand Family: THE JUXTAMEMBRANE STALK DETERMINES CLEAVAGE EFFICIENCY
J. Biol. Chem.,
June 4, 2004;
279(23):
24179 - 24188.
[Abstract]
[Full Text]
[PDF]
|
|
|
© The Company of Biologists Ltd 2004
